表紙
市場調查報告書
商品編碼
1070541

人工血管機會分析和行業預測全球市場:按產品,按原料(聚酯,聚四氟乙烯,聚氨酯,生物合成),按最終用戶(醫院,門診手術中心)2021-2030

Vascular Graft Market by Product, Raw Material (Polyester, Polytetrafluoroethylene, Polyurethane, and Biosynthetic) and End User (Hospitals and Ambulatory Surgical Centers ): Global Opportunity Analysis and Industry Forecast, 2021-2030

出版日期: | 出版商: Allied Market Research | 英文 220 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球人造血管市場預計將從2020年的49.9364億美元增長到2030年的81.3868億美元,預測期內復合年增長率為4.98%。

血管疾病患病率的增加、老年人口的增加、久坐不動的生活方式和不健康的飲食習慣的增加正在推動人造血管市場的增長。然而,人造血管的高手術成本和產品缺陷預計將成為抑制市場增長的因素。

本報告對全球人工血管市場進行研究分析,提供市場行情、市場分析、企業概況等系統信息。

目錄

第1章介紹

第2章執行摘要

第3章市場情況

  • 市場定義和範圍
  • 主要調查結果
    • 主要投資領域
    • 主要成功策略
  • 波特五力分析
    • 供應商的議價能力
    • 新進入者的威脅
    • 替代威脅
    • 競爭對手之間的敵對關係
    • 買家之間的談判權
  • 市場份額分析/主要公司定位
    • 市場份額分析/主要公司定位(2020)
  • 市場動態
    • 促進因素
    • 抑制器
    • 市場機會
  • COVID-19 影響分析

第 4 章人造血管市場:按產品分類

  • 市場概況
  • 市場規模和預測:按產品分類
  • 血液透析通路移植物
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測:按地區
    • 市場份額分析:按國家/地區分類
  • 血管內動脈瘤修復覆膜支架
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測:按地區
    • 市場份額分析:按國家/地區分類
    • 腹主動脈瘤 (AAA)
      • 市場規模和預測
    • 胸主動脈瘤 (TAA)
      • 市場規模和預測
  • 外周人工血管
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測:按地區
    • 市場份額分析:按國家/地區分類

第 5 章人造血管市場:按原料分類

  • 市場概況
  • 市場規模和預測:按原材料
  • 滌綸
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測:按地區
    • 市場份額分析:按國家/地區分類
  • 聚四氟乙烯(PTFE)
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測:按地區
    • 市場份額分析:按國家/地區分類
  • 聚氨酯
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測:按地區
    • 市場份額分析:按國家/地區分類
  • 生物合成
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測:按地區
    • 市場份額分析:按國家/地區分類

第 6 章人工血管市場:按最終用戶

  • 市場概況
  • 市場規模和預測:按最終用戶分類
  • 醫院
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測:按地區
    • 市場份額分析:按國家/地區分類
  • 門診手術中心
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測:按地區
    • 市場份額分析:按國家/地區分類

第 7 章人工血管市場:按地區劃分

  • 市場概況
  • 市場規模和預測:按地區
  • 北美
    • 主要市場趨勢和機遇
    • 市場規模和預測:按產品分類
    • 市場規模和預測:按原材料
    • 市場規模和預測:按最終用戶分類
    • 市場規模和預測:按國家/地區分類
    • 美國人造血管市場
      • 市場規模和預測:按產品分類
      • 市場規模和預測:按原材料
      • 市場規模和預測:按最終用戶分類
    • 加拿大人工血管市場
      • 市場規模和預測:按產品分類
      • 市場規模和預測:按原材料
      • 市場規模和預測:按最終用戶分類
    • 墨西哥人工血管市場
      • 市場規模和預測:按產品分類
      • 市場規模和預測:按原材料
      • 市場規模和預測:按最終用戶分類
  • 歐洲
    • 主要市場趨勢和機遇
    • 市場規模和預測:按產品分類
    • 市場規模和預測:按原材料
    • 市場規模和預測:按最終用戶分類
    • 市場規模和預測:按國家/地區分類
    • 法國人工血管市場
      • 市場規模和預測:按產品分類
      • 市場規模和預測:按原材料
      • 市場規模和預測:按最終用戶分類
    • 德國人工血管市場
      • 市場規模和預測:按產品分類
      • 市場規模和預測:按原材料
      • 市場規模和預測:按最終用戶分類
    • 意大利人工血管市場
      • 市場規模和預測:按產品分類
      • 市場規模和預測:按原材料
      • 市場規模和預測:按最終用戶分類
    • 西班牙人工血管市場
      • 市場規模和預測:按產品分類
      • 市場規模和預測:按原材料
      • 市場規模和預測:按最終用戶分類
    • 英國人工血管市場
      • 市場規模和預測:按產品分類
      • 市場規模和預測:按原材料
      • 市場規模和預測:按最終用戶分類
    • 其他歐洲人造血管市場
      • 市場規模和預測:按產品分類
      • 市場規模和預測:按原材料
      • 市場規模和預測:按最終用戶分類
  • 亞太地區
    • 主要市場趨勢和機遇
    • 市場規模和預測:按產品分類
    • 市場規模和預測:按原材料
    • 市場規模和預測:按最終用戶分類
    • 市場規模和預測:按國家/地區分類
    • 中國人造血管市場
      • 市場規模和預測:按產品分類
      • 市場規模和預測:按原材料
      • 市場規模和預測:按最終用戶分類
    • 日本人工血管市場
      • 市場規模和預測:按產品分類
      • 市場規模和預測:按原材料
      • 市場規模和預測:按最終用戶分類
    • 印度人工血管市場
      • 市場規模和預測:按產品分類
      • 市場規模和預測:按原材料
      • 市場規模和預測:按最終用戶分類
    • 韓國人工血管市場
      • 市場規模和預測:按產品分類
      • 市場規模和預測:按原材料
      • 市場規模和預測:按最終用戶分類
    • 澳大利亞人工血管市場
      • 市場規模和預測:按產品分類
      • 市場規模和預測:按原材料
      • 市場規模和預測:按最終用戶分類
    • 其他亞太人工血管市場
      • 市場規模和預測:按產品分類
      • 市場規模和預測:按原材料
      • 市場規模和預測:按最終用戶分類
  • 拉丁美洲/中東/非洲
    • 主要市場趨勢和機遇
    • 市場規模和預測:按產品分類
    • 市場規模和預測:按原材料
    • 市場規模和預測:按最終用戶分類
    • 市場規模和預測:按國家/地區分類
    • 巴西人工血管市場
      • 市場規模和預測:按產品分類
      • 市場規模和預測:按原材料
      • 市場規模和預測:按最終用戶分類
    • 南非人工血管市場
      • 市場規模和預測:按產品分類
      • 市場規模和預測:按原材料
      • 市場規模和預測:按最終用戶分類
    • 沙特阿拉伯的人造血管市場
      • 市場規模和預測:按產品分類
      • 市場規模和預測:按原材料
      • 市場規模和預測:按最終用戶分類
    • 其他拉丁美洲/中東/非洲人工血管市場
      • 市場規模和預測:按產品分類
      • 市場規模和預測:按原材料
      • 市場規模和預測:按最終用戶分類

第 8 章公司簡介

  • B. Braun Melsungen AG
  • Becton, Dickinson And Company
  • Cook Medical Inc
  • Cordis
  • Endologix Inc.
  • Getinge Group
  • LeMaitre Vascular Inc.
  • Medtronic, Inc.
  • TERUMO MEDICAL CORPORATION
  • W. L. Gore And Associates, Inc.
目錄
Product Code: LI_172435 / A02104

The global vascular graft market was valued at $4,993.64 million in 2020, and is projected to reach $8,138.68 million by 2030, registering a CAGR of 4.98% from 2021 to 2030..

A vascular graft is a surgical procedure that redirects blood flow from one area of the body to another by reconnecting the blood vessels. Vascular grafts are used for the treatment of vascular diseases such as pulmonary embolism (blood clots), deep vein thrombosis (DVT), chronic venous insufficiency (CVI), and varicose veins. The incidence of vascular diseases has increased significantly over the last few years. According to the World Health Organization (WHO), an estimated 17.9 million people died from cardiovascular diseases (CVDs) in 2019. Vascular diseases may be caused due to high blood pressure, cholesterol deposition, injury, genetic, and infections.

Vascular grafts are mainly made of polyester, polytetrafluoroethylene (PTFE), and polyurethane material. However, biosynthetic vascular grafts are also available in market. The vascular grafts are classified as hemodialysis access graft, endovascular aneurysm repair stent grafts, and peripheral vascular graft. Endovascular stent grafting, or endovascular aneurysm repair (EVAR), is a newer form of treatment for abdominal aortic aneurysm that is less invasive than open surgery. Endovascular stent graft is used to reinforce the wall of the aorta and to help keep the damaged area from rupturing.

The increase in the prevalence of vascular diseases globally drives the growth of vascular grafts market. For instance, according to report by American Heart Association, in 2019, 197.2 million people lived with ischemic heart disease (IHD). In addition, the increase in diabetes and hypertension propels the growth of vascular disease devices market. According to World Health Organization (WHO) in 2021, an estimated 1.28 billion adults aged 30-79 years had hypertension. The older age people are more susceptible to vascular disease and the rise in the geriatric population further contributes in the growth of the vascular grafts market.

In addition, increase in the sedentary lifestyle and unhealthy food eating habits contribute in the growth of the vascular grafts market. However, the high cost of vascular surgery and product failures are expected to limit the growth of the market.

.

The vascular grafts market is segmented on the basis of product, raw material, end user, and regions. By product, the market is mainly categorized into hemodialysis access graft, endovascular aneurysm repair stent grafts, and peripheral vascular graft. Endovascular aneurysm repair stent grafts are further subcategorized into abdominal aortic aneurysm (AAA) and thoracic aortic aneurysm (TAA). By raw material, it is categorized in to polyester, polytetrafluoroethylene (PTFE), polyurethane, and biosynthetic. By end user, it is divided into hospitals and ambulatory surgical centers (ASCs). By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The major companies profiled in the report include B. Braun Melsungen AG, Becton, Dickinson And Company, Cook Medical, Inc., Cordis, Endologix Inc., Getinge Group, LeMaitre Vascular Inc., Medtronic plc, Terumo Medical Corporation and W. L. Gore & Associates, Inc.

KEY BENEFITS FOR STAKEHOLDERS

  • The report provides an in-depth analysis of the global vascular grafts market size along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It offers market analysis from 2021 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
  • A comprehensive analysis of the region assists to understand the regional market and facilitate strategic business planning and determine prevailing opportunities.
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global vascular grafts market growth.

KEY MARKET SEGMENTS

  • By Product
    • Hemodialysis Access Graft
    • Endovascular Aneurysm Repair Stent Grafts
      • Abdominal Aortic Aneurysm (AAA)
      • Thoracic Aortic Aneurysm (TAA)
    • Peripheral Vascular Graft
  • By Raw Material
    • Polyester
    • Polytetrafluoroethylene (PTFE)
    • Polyurethane
    • Biosynthetic
  • By End User
    • Hospitals
    • Ambulatory Surgical Centers (ASCs)
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • UK
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific
      • Japan
      • China
      • Australia
      • India
      • South Korea
      • Rest of Asia Pacific
    • LAMEA
      • Brazil
      • Saudi Arabia
      • South Africa
      • Rest of LAMEA

KEY MARKET PLAYERS

  • B. Braun Melsungen AG
  • Becton, Dickinson And Company
  • Cook Medical, Inc.
  • Cordis
  • Endologix Inc.
  • Getinge Group
  • LeMaitre Vascular Inc.
  • Medtronic plc
  • Terumo Medical Corporation
  • W. L. Gore & Associates, Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1.Report Description
  • 1.2.Key Market Segments
  • 1.3.Key Benefits
  • 1.4.Research Methodology
    • 1.4.1.Primary Research
    • 1.4.2.Secondary Research
    • 1.4.3.Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1.CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1.Market Definition and Scope
  • 3.2.Key Findings
    • 3.2.1.Top Investment Pockets
    • 3.2.2.Top Winning Strategies
  • 3.3.Porter's Five Forces Analysis
    • 3.3.1.Bargaining Power of Suppliers
    • 3.3.2.Threat of New Entrants
    • 3.3.3.Threat of Substitutes
    • 3.3.4.Competitive Rivalry
    • 3.3.5.Bargaining Power among Buyers
  • 3.4.Market Share Analysis/Top Player Positioning
    • 3.4.1.Market Share Analysis/Top Player Positioning 2020
  • 3.5.Market Dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6. COVID-19 Impact Analysis

CHAPTER 4: VASCULAR GRAFT MARKET, BY PRODUCTS

  • 4.1.Market Overview
  • 4.1.1Market Size and Forecast, By Products
  • 4.2.Hemodialysis Access Graft
    • 4.2.1.Key Market Trends, Growth Factors and Opportunities
    • 4.2.2.Market Size and Forecast, By Region
    • 4.2.3.Market Share Analysis, By Country
  • 4.3.Endovascular Aneurysm Repair Stent Grafts
    • 4.3.1.Key Market Trends, Growth Factors and Opportunities
    • 4.3.2.Market Size and Forecast, By Region
    • 4.3.3.Market Share Analysis, By Country
    • 4.3.4.Abdominal Aortic Aneurysm (AAA)
      • 4.3.4.1.Market Size and Forecast
    • 4.3.5.Thoracic Aortic Aneurysm (TAA)
      • 4.3.5.1.Market Size and Forecast
  • 4.4.Peripheral Vascular Graft
    • 4.4.1.Key Market Trends, Growth Factors and Opportunities
    • 4.4.2.Market Size and Forecast, By Region
    • 4.4.3.Market Share Analysis, By Country

CHAPTER 5: VASCULAR GRAFT MARKET, BY RAW MATERIAL

  • 5.1.Market Overview
  • 5.1.1Market Size and Forecast, By Raw Material
  • 5.2.Polyester
    • 5.2.1.Key Market Trends, Growth Factors and Opportunities
    • 5.2.2.Market Size and Forecast, By Region
    • 5.2.3.Market Share Analysis, By Country
  • 5.3.Polytetrafluoroethylene (PTFE)
    • 5.3.1.Key Market Trends, Growth Factors and Opportunities
    • 5.3.2.Market Size and Forecast, By Region
    • 5.3.3.Market Share Analysis, By Country
  • 5.4.Polyurethane
    • 5.4.1.Key Market Trends, Growth Factors and Opportunities
    • 5.4.2.Market Size and Forecast, By Region
    • 5.4.3.Market Share Analysis, By Country
  • 5.5.Biosynthetic
    • 5.5.1.Key Market Trends, Growth Factors and Opportunities
    • 5.5.2.Market Size and Forecast, By Region
    • 5.5.3.Market Share Analysis, By Country

CHAPTER 6: VASCULAR GRAFT MARKET, BY END USER

  • 6.1.Market Overview
  • 6.1.1Market Size and Forecast, By End User
  • 6.2.Hospitals
    • 6.2.1.Key Market Trends, Growth Factors and Opportunities
    • 6.2.2.Market Size and Forecast, By Region
    • 6.2.3.Market Share Analysis, By Country
  • 6.3.Ambulatory Surgical Centers (ASCs)
    • 6.3.1.Key Market Trends, Growth Factors and Opportunities
    • 6.3.2.Market Size and Forecast, By Region
    • 6.3.3.Market Share Analysis, By Country

CHAPTER 7: VASCULAR GRAFT MARKET, BY REGION

  • 7.1.Market Overview
  • 7.1.1Market Size and Forecast, By Region
  • 7.2.North America
    • 7.2.1.Key Market Trends and Opportunities
    • 7.2.2.Market Size and Forecast, By Products
    • 7.2.3.Market Size and Forecast, By Raw Material
    • 7.2.4.Market Size and Forecast, By End User
    • 7.2.5.Market Size and Forecast, By Country
    • 7.2.6.United States Vascular Graft Market
      • 7.2.6.1.Market Size and Forecast, By Products
      • 7.2.6.2.Market Size and Forecast, By Raw Material
      • 7.2.6.3.Market Size and Forecast, By End User
    • 7.2.7.Canada Vascular Graft Market
      • 7.2.7.1.Market Size and Forecast, By Products
      • 7.2.7.2.Market Size and Forecast, By Raw Material
      • 7.2.7.3.Market Size and Forecast, By End User
    • 7.2.8.Mexico Vascular Graft Market
      • 7.2.8.1.Market Size and Forecast, By Products
      • 7.2.8.2.Market Size and Forecast, By Raw Material
      • 7.2.8.3.Market Size and Forecast, By End User
  • 7.3.Europe
    • 7.3.1.Key Market Trends and Opportunities
    • 7.3.2.Market Size and Forecast, By Products
    • 7.3.3.Market Size and Forecast, By Raw Material
    • 7.3.4.Market Size and Forecast, By End User
    • 7.3.5.Market Size and Forecast, By Country
    • 7.3.6.France Vascular Graft Market
      • 7.3.6.1.Market Size and Forecast, By Products
      • 7.3.6.2.Market Size and Forecast, By Raw Material
      • 7.3.6.3.Market Size and Forecast, By End User
    • 7.3.7.Germany Vascular Graft Market
      • 7.3.7.1.Market Size and Forecast, By Products
      • 7.3.7.2.Market Size and Forecast, By Raw Material
      • 7.3.7.3.Market Size and Forecast, By End User
    • 7.3.8.Italy Vascular Graft Market
      • 7.3.8.1.Market Size and Forecast, By Products
      • 7.3.8.2.Market Size and Forecast, By Raw Material
      • 7.3.8.3.Market Size and Forecast, By End User
    • 7.3.9.Spain Vascular Graft Market
      • 7.3.9.1.Market Size and Forecast, By Products
      • 7.3.9.2.Market Size and Forecast, By Raw Material
      • 7.3.9.3.Market Size and Forecast, By End User
    • 7.3.10.U.K Vascular Graft Market
      • 7.3.10.1.Market Size and Forecast, By Products
      • 7.3.10.2.Market Size and Forecast, By Raw Material
      • 7.3.10.3.Market Size and Forecast, By End User
    • 7.3.11.Rest Of Europe Vascular Graft Market
      • 7.3.11.1.Market Size and Forecast, By Products
      • 7.3.11.2.Market Size and Forecast, By Raw Material
      • 7.3.11.3.Market Size and Forecast, By End User
  • 7.4.Asia-Pacific
    • 7.4.1.Key Market Trends and Opportunities
    • 7.4.2.Market Size and Forecast, By Products
    • 7.4.3.Market Size and Forecast, By Raw Material
    • 7.4.4.Market Size and Forecast, By End User
    • 7.4.5.Market Size and Forecast, By Country
    • 7.4.6.China Vascular Graft Market
      • 7.4.6.1.Market Size and Forecast, By Products
      • 7.4.6.2.Market Size and Forecast, By Raw Material
      • 7.4.6.3.Market Size and Forecast, By End User
    • 7.4.7.Japan Vascular Graft Market
      • 7.4.7.1.Market Size and Forecast, By Products
      • 7.4.7.2.Market Size and Forecast, By Raw Material
      • 7.4.7.3.Market Size and Forecast, By End User
    • 7.4.8.India Vascular Graft Market
      • 7.4.8.1.Market Size and Forecast, By Products
      • 7.4.8.2.Market Size and Forecast, By Raw Material
      • 7.4.8.3.Market Size and Forecast, By End User
    • 7.4.9.South Korea Vascular Graft Market
      • 7.4.9.1.Market Size and Forecast, By Products
      • 7.4.9.2.Market Size and Forecast, By Raw Material
      • 7.4.9.3.Market Size and Forecast, By End User
    • 7.4.10.Australia Vascular Graft Market
      • 7.4.10.1.Market Size and Forecast, By Products
      • 7.4.10.2.Market Size and Forecast, By Raw Material
      • 7.4.10.3.Market Size and Forecast, By End User
    • 7.4.11.Rest of Asia Pacific Vascular Graft Market
      • 7.4.11.1.Market Size and Forecast, By Products
      • 7.4.11.2.Market Size and Forecast, By Raw Material
      • 7.4.11.3.Market Size and Forecast, By End User
  • 7.5.LAMEA
    • 7.5.1.Key Market Trends and Opportunities
    • 7.5.2.Market Size and Forecast, By Products
    • 7.5.3.Market Size and Forecast, By Raw Material
    • 7.5.4.Market Size and Forecast, By End User
    • 7.5.5.Market Size and Forecast, By Country
    • 7.5.6.Brazil Vascular Graft Market
      • 7.5.6.1.Market Size and Forecast, By Products
      • 7.5.6.2.Market Size and Forecast, By Raw Material
      • 7.5.6.3.Market Size and Forecast, By End User
    • 7.5.7.South Africa, Vascular Graft Market
      • 7.5.7.1.Market Size and Forecast, By Products
      • 7.5.7.2.Market Size and Forecast, By Raw Material
      • 7.5.7.3.Market Size and Forecast, By End User
    • 7.5.8.Saudi Arabia Vascular Graft Market
      • 7.5.8.1.Market Size and Forecast, By Products
      • 7.5.8.2.Market Size and Forecast, By Raw Material
      • 7.5.8.3.Market Size and Forecast, By End User
    • 7.5.9.Rest of LAMEA Vascular Graft Market
      • 7.5.9.1.Market Size and Forecast, By Products
      • 7.5.9.2.Market Size and Forecast, By Raw Material
      • 7.5.9.3.Market Size and Forecast, By End User

CHAPTER 8: COMPANY PROFILES

  • 8.1.B. Braun Melsungen AG
    • 8.1.1.Company Overview
    • 8.1.2.Key Executives
    • 8.1.3.Company snapshot
    • 8.1.4.Operating business segments
    • 8.1.5.Product portfolio
    • 8.1.6.Business Performance
    • 8.1.7.Key Strategic Moves and Developments
  • 8.2.Becton, Dickinson And Company
    • 8.2.1.Company Overview
    • 8.2.2.Key Executives
    • 8.2.3.Company snapshot
    • 8.2.4.Operating business segments
    • 8.2.5.Product portfolio
    • 8.2.6.Business Performance
    • 8.2.7.Key Strategic Moves and Developments
  • 8.3.Cook Medical Inc
    • 8.3.1.Company Overview
    • 8.3.2.Key Executives
    • 8.3.3.Company snapshot
    • 8.3.4.Operating business segments
    • 8.3.5.Product portfolio
    • 8.3.6.Business Performance
    • 8.3.7.Key Strategic Moves and Developments
  • 8.4.Cordis
    • 8.4.1.Company Overview
    • 8.4.2.Key Executives
    • 8.4.3.Company snapshot
    • 8.4.4.Operating business segments
    • 8.4.5.Product portfolio
    • 8.4.6.Business Performance
    • 8.4.7.Key Strategic Moves and Developments
  • 8.5.Endologix Inc.
    • 8.5.1.Company Overview
    • 8.5.2.Key Executives
    • 8.5.3.Company snapshot
    • 8.5.4.Operating business segments
    • 8.5.5.Product portfolio
    • 8.5.6.Business Performance
    • 8.5.7.Key Strategic Moves and Developments
  • 8.6.Getinge Group
    • 8.6.1.Company Overview
    • 8.6.2.Key Executives
    • 8.6.3.Company snapshot
    • 8.6.4.Operating business segments
    • 8.6.5.Product portfolio
    • 8.6.6.Business Performance
    • 8.6.7.Key Strategic Moves and Developments
  • 8.7.LeMaitre Vascular Inc.
    • 8.7.1.Company Overview
    • 8.7.2.Key Executives
    • 8.7.3.Company snapshot
    • 8.7.4.Operating business segments
    • 8.7.5.Product portfolio
    • 8.7.6.Business Performance
    • 8.7.7.Key Strategic Moves and Developments
  • 8.8.Medtronic, Inc.
    • 8.8.1.Company Overview
    • 8.8.2.Key Executives
    • 8.8.3.Company snapshot
    • 8.8.4.Operating business segments
    • 8.8.5.Product portfolio
    • 8.8.6.Business Performance
    • 8.8.7.Key Strategic Moves and Developments
  • 8.9.TERUMO MEDICAL CORPORATION
    • 8.9.1.Company Overview
    • 8.9.2.Key Executives
    • 8.9.3.Company snapshot
    • 8.9.4.Operating business segments
    • 8.9.5.Product portfolio
    • 8.9.6.Business Performance
    • 8.9.7.Key Strategic Moves and Developments
  • 8.10.W. L. Gore And Associates, Inc.
    • 8.10.1.Company Overview
    • 8.10.2.Key Executives
    • 8.10.3.Company snapshot
    • 8.10.4.Operating business segments
    • 8.10.5.Product portfolio
    • 8.10.6.Business Performance
    • 8.10.7.Key Strategic Moves and Developments

LIST OF TABLES

  • TABLE 1.GLOBAL VASCULAR GRAFT MARKET, BY PRODUCTS, 2020-2030 ($MILLION)
  • TABLE 2.GLOBAL VASCULAR GRAFT MARKET FOR HEMODIALYSIS ACCESS GRAFT, BY REGION, 2020-2030 ($MILLION)
  • TABLE 3.GLOBAL VASCULAR GRAFT MARKET FOR ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 4.GLOBAL VASCULAR GRAFT MARKET FOR PERIPHERAL VASCULAR GRAFT, BY REGION, 2020-2030 ($MILLION)
  • TABLE 5.GLOBAL VASCULAR GRAFT MARKET, BY RAW MATERIAL, 2020-2030 ($MILLION)
  • TABLE 6.GLOBAL VASCULAR GRAFT MARKET FOR POLYESTER, BY REGION, 2020-2030 ($MILLION)
  • TABLE 7.GLOBAL VASCULAR GRAFT MARKET FOR POLYTETRAFLUOROETHYLENE (PTFE), BY REGION, 2020-2030 ($MILLION)
  • TABLE 8.GLOBAL VASCULAR GRAFT MARKET FOR POLYURETHANE, BY REGION, 2020-2030 ($MILLION)
  • TABLE 9.GLOBAL VASCULAR GRAFT MARKET FOR BIOSYNTHETIC, BY REGION, 2020-2030 ($MILLION)
  • TABLE 10.GLOBAL VASCULAR GRAFT MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 11.GLOBAL VASCULAR GRAFT MARKET FOR HOSPITALS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 12.GLOBAL VASCULAR GRAFT MARKET FOR AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2020-2030 ($MILLION)
  • TABLE 13.GLOBAL VASCULAR GRAFT MARKET, BY REGION, 2020-2030 ($MILLION)
  • TABLE 14.NORTH AMERICA VASCULAR GRAFT, BY PRODUCTS, 2020-2030 ($MILLION)
  • TABLE 15.NORTH AMERICA VASCULAR GRAFT, BY RAW MATERIAL, 2020-2030 ($MILLION)
  • TABLE 16.NORTH AMERICA VASCULAR GRAFT, BY END USER, 2020-2030 ($MILLION)
  • TABLE 17.UNITED STATES VASCULAR GRAFT, BY PRODUCTS, 2020-2030 ($MILLION)
  • TABLE 18.UNITED STATES VASCULAR GRAFT, BY RAW MATERIAL, 2020-2030 ($MILLION)
  • TABLE 19.UNITED STATES VASCULAR GRAFT, BY END USER, 2020-2030 ($MILLION)
  • TABLE 20.CANADA VASCULAR GRAFT, BY PRODUCTS, 2020-2030 ($MILLION)
  • TABLE 21.CANADA VASCULAR GRAFT, BY RAW MATERIAL, 2020-2030 ($MILLION)
  • TABLE 22.CANADA VASCULAR GRAFT, BY END USER, 2020-2030 ($MILLION)
  • TABLE 23.MEXICO VASCULAR GRAFT, BY PRODUCTS, 2020-2030 ($MILLION)
  • TABLE 24.MEXICO VASCULAR GRAFT, BY RAW MATERIAL, 2020-2030 ($MILLION)
  • TABLE 25.MEXICO VASCULAR GRAFT, BY END USER, 2020-2030 ($MILLION)
  • TABLE 26.EUROPE VASCULAR GRAFT, BY PRODUCTS, 2020-2030 ($MILLION)
  • TABLE 27.EUROPE VASCULAR GRAFT, BY RAW MATERIAL, 2020-2030 ($MILLION)
  • TABLE 28.EUROPE VASCULAR GRAFT, BY END USER, 2020-2030 ($MILLION)
  • TABLE 29.FRANCE VASCULAR GRAFT, BY PRODUCTS, 2020-2030 ($MILLION)
  • TABLE 30.FRANCE VASCULAR GRAFT, BY RAW MATERIAL, 2020-2030 ($MILLION)
  • TABLE 31.FRANCE VASCULAR GRAFT, BY END USER, 2020-2030 ($MILLION)
  • TABLE 32.GERMANY VASCULAR GRAFT, BY PRODUCTS, 2020-2030 ($MILLION)
  • TABLE 33.GERMANY VASCULAR GRAFT, BY RAW MATERIAL, 2020-2030 ($MILLION)
  • TABLE 34.GERMANY VASCULAR GRAFT, BY END USER, 2020-2030 ($MILLION)
  • TABLE 35.ITALY VASCULAR GRAFT, BY PRODUCTS, 2020-2030 ($MILLION)
  • TABLE 36.ITALY VASCULAR GRAFT, BY RAW MATERIAL, 2020-2030 ($MILLION)
  • TABLE 37.ITALY VASCULAR GRAFT, BY END USER, 2020-2030 ($MILLION)
  • TABLE 38.SPAIN VASCULAR GRAFT, BY PRODUCTS, 2020-2030 ($MILLION)
  • TABLE 39.SPAIN VASCULAR GRAFT, BY RAW MATERIAL, 2020-2030 ($MILLION)
  • TABLE 40.SPAIN VASCULAR GRAFT, BY END USER, 2020-2030 ($MILLION)
  • TABLE 41.UNITED KINGDOM VASCULAR GRAFT, BY PRODUCTS, 2020-2030 ($MILLION)
  • TABLE 42.UNITED KINGDOM VASCULAR GRAFT, BY RAW MATERIAL, 2020-2030 ($MILLION)
  • TABLE 43.UNITED KINGDOM VASCULAR GRAFT, BY END USER, 2020-2030 ($MILLION)
  • TABLE 44.REST OF EUROPE VASCULAR GRAFT, BY PRODUCTS, 2020-2030 ($MILLION)
  • TABLE 45.REST OF EUROPE VASCULAR GRAFT, BY RAW MATERIAL, 2020-2030 ($MILLION)
  • TABLE 46.REST OF EUROPE VASCULAR GRAFT, BY END USER, 2020-2030 ($MILLION)
  • TABLE 47.ASIA-PACIFIC VASCULAR GRAFT, BY PRODUCTS, 2020-2030 ($MILLION)
  • TABLE 48.ASIA-PACIFIC VASCULAR GRAFT, BY RAW MATERIAL, 2020-2030 ($MILLION)
  • TABLE 49.ASIA-PACIFIC VASCULAR GRAFT, BY END USER, 2020-2030 ($MILLION)
  • TABLE 50.CHINA VASCULAR GRAFT, BY PRODUCTS, 2020-2030 ($MILLION)
  • TABLE 51.CHINA VASCULAR GRAFT, BY RAW MATERIAL, 2020-2030 ($MILLION)
  • TABLE 52.CHINA VASCULAR GRAFT, BY END USER, 2020-2030 ($MILLION)
  • TABLE 53.JAPAN VASCULAR GRAFT, BY PRODUCTS, 2020-2030 ($MILLION)
  • TABLE 54.JAPAN VASCULAR GRAFT, BY RAW MATERIAL, 2020-2030 ($MILLION)
  • TABLE 55.JAPAN VASCULAR GRAFT, BY END USER, 2020-2030 ($MILLION)
  • TABLE 56.INDIA VASCULAR GRAFT, BY PRODUCTS, 2020-2030 ($MILLION)
  • TABLE 57.INDIA VASCULAR GRAFT, BY RAW MATERIAL, 2020-2030 ($MILLION)
  • TABLE 58.INDIA VASCULAR GRAFT, BY END USER, 2020-2030 ($MILLION)
  • TABLE 59.SOUTH KOREA VASCULAR GRAFT, BY PRODUCTS, 2020-2030 ($MILLION)
  • TABLE 60.SOUTH KOREA VASCULAR GRAFT, BY RAW MATERIAL, 2020-2030 ($MILLION)
  • TABLE 61.SOUTH KOREA VASCULAR GRAFT, BY END USER, 2020-2030 ($MILLION)
  • TABLE 62.AUSTRALIA VASCULAR GRAFT, BY PRODUCTS, 2020-2030 ($MILLION)
  • TABLE 63.AUSTRALIA VASCULAR GRAFT, BY RAW MATERIAL, 2020-2030 ($MILLION)
  • TABLE 64.AUSTRALIA VASCULAR GRAFT, BY END USER, 2020-2030 ($MILLION)
  • TABLE 65.REST OF ASIA PACIFIC VASCULAR GRAFT, BY PRODUCTS, 2020-2030 ($MILLION)
  • TABLE 66.REST OF ASIA PACIFIC VASCULAR GRAFT, BY RAW MATERIAL, 2020-2030 ($MILLION)
  • TABLE 67.REST OF ASIA PACIFIC VASCULAR GRAFT, BY END USER, 2020-2030 ($MILLION)
  • TABLE 68.LAMEA VASCULAR GRAFT, BY PRODUCTS, 2020-2030 ($MILLION)
  • TABLE 69.LAMEA VASCULAR GRAFT, BY RAW MATERIAL, 2020-2030 ($MILLION)
  • TABLE 70.LAMEA VASCULAR GRAFT, BY END USER, 2020-2030 ($MILLION)
  • TABLE 71.BRAZIL VASCULAR GRAFT, BY PRODUCTS, 2020-2030 ($MILLION)
  • TABLE 72.BRAZIL VASCULAR GRAFT, BY RAW MATERIAL, 2020-2030 ($MILLION)
  • TABLE 73.BRAZIL VASCULAR GRAFT, BY END USER, 2020-2030 ($MILLION)
  • TABLE 74.SOUTH AFRICA, VASCULAR GRAFT, BY PRODUCTS, 2020-2030 ($MILLION)
  • TABLE 75.SOUTH AFRICA, VASCULAR GRAFT, BY RAW MATERIAL, 2020-2030 ($MILLION)
  • TABLE 76.SOUTH AFRICA, VASCULAR GRAFT, BY END USER, 2020-2030 ($MILLION)
  • TABLE 77.SAUDI ARABIA VASCULAR GRAFT, BY PRODUCTS, 2020-2030 ($MILLION)
  • TABLE 78.SAUDI ARABIA VASCULAR GRAFT, BY RAW MATERIAL, 2020-2030 ($MILLION)
  • TABLE 79.SAUDI ARABIA VASCULAR GRAFT, BY END USER, 2020-2030 ($MILLION)
  • TABLE 80.REST OF LAMEA VASCULAR GRAFT, BY PRODUCTS, 2020-2030 ($MILLION)
  • TABLE 81.REST OF LAMEA VASCULAR GRAFT, BY RAW MATERIAL, 2020-2030 ($MILLION)
  • TABLE 82.REST OF LAMEA VASCULAR GRAFT, BY END USER, 2020-2030 ($MILLION)
  • TABLE 83.B. BRAUN MELSUNGEN AG: KEY EXECUTIVES
  • TABLE 84.B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
  • TABLE 85.B. BRAUN MELSUNGEN AG: OPERATING SEGMENTS
  • TABLE 86.B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
  • TABLE 87.B. BRAUN MELSUNGEN AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 88.BECTON, DICKINSON AND COMPANY: KEY EXECUTIVES
  • TABLE 89.BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
  • TABLE 90.BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS
  • TABLE 91.BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
  • TABLE 92.BECTON, DICKINSON AND COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 93.COOK MEDICAL INC: KEY EXECUTIVES
  • TABLE 94.COOK MEDICAL INC: COMPANY SNAPSHOT
  • TABLE 95.COOK MEDICAL INC: OPERATING SEGMENTS
  • TABLE 96.COOK MEDICAL INC: PRODUCT PORTFOLIO
  • TABLE 97.COOK MEDICAL INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 98.CORDIS: KEY EXECUTIVES
  • TABLE 99.CORDIS: COMPANY SNAPSHOT
  • TABLE 100.CORDIS: OPERATING SEGMENTS
  • TABLE 101.CORDIS: PRODUCT PORTFOLIO
  • TABLE 102.CORDIS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 103.ENDOLOGIX INC.: KEY EXECUTIVES
  • TABLE 104.ENDOLOGIX INC.: COMPANY SNAPSHOT
  • TABLE 105.ENDOLOGIX INC.: OPERATING SEGMENTS
  • TABLE 106.ENDOLOGIX INC.: PRODUCT PORTFOLIO
  • TABLE 107.ENDOLOGIX INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 108.GETINGE GROUP: KEY EXECUTIVES
  • TABLE 109.GETINGE GROUP: COMPANY SNAPSHOT
  • TABLE 110.GETINGE GROUP: OPERATING SEGMENTS
  • TABLE 111.GETINGE GROUP: PRODUCT PORTFOLIO
  • TABLE 112.GETINGE GROUP: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 113.LEMAITRE VASCULAR INC.: KEY EXECUTIVES
  • TABLE 114.LEMAITRE VASCULAR INC.: COMPANY SNAPSHOT
  • TABLE 115.LEMAITRE VASCULAR INC.: OPERATING SEGMENTS
  • TABLE 116.LEMAITRE VASCULAR INC.: PRODUCT PORTFOLIO
  • TABLE 117.LEMAITRE VASCULAR INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 118.MEDTRONIC, INC.: KEY EXECUTIVES
  • TABLE 119.MEDTRONIC, INC.: COMPANY SNAPSHOT
  • TABLE 120.MEDTRONIC, INC.: OPERATING SEGMENTS
  • TABLE 121.MEDTRONIC, INC.: PRODUCT PORTFOLIO
  • TABLE 122.MEDTRONIC, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 123.TERUMO MEDICAL CORPORATION: KEY EXECUTIVES
  • TABLE 124.TERUMO MEDICAL CORPORATION: COMPANY SNAPSHOT
  • TABLE 125.TERUMO MEDICAL CORPORATION: OPERATING SEGMENTS
  • TABLE 126.TERUMO MEDICAL CORPORATION: PRODUCT PORTFOLIO
  • TABLE 127.TERUMO MEDICAL CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 128.W. L. GORE AND ASSOCIATES, INC.: KEY EXECUTIVES
  • TABLE 129.W. L. GORE AND ASSOCIATES, INC.: COMPANY SNAPSHOT
  • TABLE 130.W. L. GORE AND ASSOCIATES, INC.: OPERATING SEGMENTS
  • TABLE 131.W. L. GORE AND ASSOCIATES, INC.: PRODUCT PORTFOLIO
  • TABLE 132.W. L. GORE AND ASSOCIATES, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

  • FIGURE 1.GLOBAL VASCULAR GRAFT MARKET SEGMENTATION
  • FIGURE 2.GLOBAL VASCULAR GRAFT MARKET
  • FIGURE 3.SEGMENTATION VASCULAR GRAFT MARKET
  • FIGURE 4.TOP INVESTMENT POCKET IN VASCULAR GRAFT MARKET
  • FIGURE 5.TOP WINNING STRATEGIES, 2019-2021*
  • FIGURE 6.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2019-2021(%)
  • FIGURE 7.TOP WINNING STRATEGIES, BY COMPANY, 2019-2021*
  • FIGURE 8.MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 9.MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 10.MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 11.LOW THREAT OF SUBSTITUTION
  • FIGURE 12.HIGH COMPETITIVE RIVALRY
  • FIGURE 13.TOP PLAYER POSITIONING, 2020
  • FIGURE 14.MARKET SHARE ANALYSIS, 2020
  • FIGURE 15.RESTRAINTS AND DRIVERS: VASCULAR GRAFT MARKET
  • FIGURE 16.VASCULAR GRAFT MARKET SEGMENTATION, BY PRODUCTS
  • FIGURE 17.VASCULAR GRAFT MARKET FOR HEMODIALYSIS ACCESS GRAFT, BY COUNTRY, 2020-2030 ($MILLION)
  • FIGURE 18.VASCULAR GRAFT MARKET FOR ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS, BY COUNTRY, 2020-2030 ($MILLION)
  • FIGURE 19.VASCULAR GRAFT MARKET FOR PERIPHERAL VASCULAR GRAFT, BY COUNTRY, 2020-2030 ($MILLION)
  • FIGURE 20.VASCULAR GRAFT MARKET SEGMENTATION, BY RAW MATERIAL
  • FIGURE 21.VASCULAR GRAFT MARKET FOR POLYESTER, BY COUNTRY, 2020-2030 ($MILLION)
  • FIGURE 22.VASCULAR GRAFT MARKET FOR POLYTETRAFLUOROETHYLENE (PTFE), BY COUNTRY, 2020-2030 ($MILLION)
  • FIGURE 23.VASCULAR GRAFT MARKET FOR POLYURETHANE, BY COUNTRY, 2020-2030 ($MILLION)
  • FIGURE 24.VASCULAR GRAFT MARKET FOR BIOSYNTHETIC, BY COUNTRY, 2020-2030 ($MILLION)
  • FIGURE 25.VASCULAR GRAFT MARKET SEGMENTATION, BY END USER
  • FIGURE 26.VASCULAR GRAFT MARKET FOR HOSPITALS, BY COUNTRY, 2020-2030 ($MILLION)
  • FIGURE 27.VASCULAR GRAFT MARKET FOR AMBULATORY SURGICAL CENTERS (ASCS), BY COUNTRY, 2020-2030 ($MILLION)
  • FIGURE 28.B. BRAUN MELSUNGEN AG: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 29.B. BRAUN MELSUNGEN AG: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 30.B. BRAUN MELSUNGEN AG: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 31.BECTON, DICKINSON AND COMPANY: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 32.BECTON, DICKINSON AND COMPANY: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 33.BECTON, DICKINSON AND COMPANY: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 34.COOK MEDICAL INC: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 35.COOK MEDICAL INC: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 36.COOK MEDICAL INC: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 37.CORDIS: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 38.CORDIS: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 39.CORDIS: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 40.ENDOLOGIX INC.: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 41.ENDOLOGIX INC.: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 42.ENDOLOGIX INC.: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 43.GETINGE GROUP: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 44.GETINGE GROUP: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 45.GETINGE GROUP: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 46.LEMAITRE VASCULAR INC.: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 47.LEMAITRE VASCULAR INC.: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 48.LEMAITRE VASCULAR INC.: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 49.MEDTRONIC, INC.: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 50.MEDTRONIC, INC.: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 51.MEDTRONIC, INC.: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 52.TERUMO MEDICAL CORPORATION: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 53.TERUMO MEDICAL CORPORATION: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 54.TERUMO MEDICAL CORPORATION: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 55.W. L. GORE AND ASSOCIATES, INC.: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 56.W. L. GORE AND ASSOCIATES, INC.: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 57.W. L. GORE AND ASSOCIATES, INC.: REVENUE SHARE, BY REGION, 2020 (%)